M. Wayne Saville, M.D.

HIV infection carries with it a high susceptibility to certain cancers, most notably, Kaposi's sarcoma (KS) and Hodgkin's and non-Hodgkin's lymphoma. At the 4th International AIDS Malignancy Conference, sponsored by the National Cancer Institute, the latest findings on malignancies in AIDS, transplantation and other types of immune deficiencies were presented. Covering this conference for The Body was M. Wayne Saville, M.D. from the University of California-San Diego. Dr. Saville has done extensive research on AIDS-related cancers, specifically Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma.

Funding for this conference coverage at The Body was provided, in part, by an unrestricted educational grant from Ligand Pharmaceuticals.

Conference Summaries

• Epidemiology and Distribution of the AIDS-Related Cancers
  Coverage by M. Wayne Saville, M.D.

• Transmission of Human Herpes Virus Type 8 (HHV-8, The Kaposi's Sarcoma-Associated Herpes Virus)
  Coverage by M. Wayne Saville, M.D.

• Treatment of AIDS Lymphoma (AIDS-NHL)
  Coverage by M. Wayne Saville, M.D.

• Abstracts 60 and S19
  Coverage by M. Wayne Saville, M.D.
  • Abstract 60: Mobilization of Peripheral Blood Progenitor Cells and Engraftment Following High-Dose Chemotherapy for AIDS-Lymphoma.
    Authors: Krishnan, Molina, Zaia et al.
    
    
  • Abstract S19: Treatment of AIDS Lymphoma with High-Dose Chemotherapy and Genetically Modified Stem Cells: A Model for Evaluation of Gene Therapy.
    Authors: Zaia, Krishnan, Rossi, et al.

• Abstract 31: Efficacy and Safety of Long-Term Alitretinoin Gel (Panretin®) for Cutaneous AIDS-Related Kaposi's Sarcoma.
  Authors: Tompkins C., Kean Y., Yocum R., and the Panretin® Gel North American Study Group.
  Coverage by M. Wayne Saville, M.D.